Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Volume XXXII, No. 4 - March 10, 2025

Medical Robotics Developer Believes It’s Time to Transform Phlebotomy

Phlebotomy and collection of veinous blood is one important procedure in clinical laboratory testing that continues to be primarily a manual process. That is about to change. Netherlands-based Vitestro has obtained a CE mark in the European Union for its novel autonomous robotic phlebotomy device (ARPD), which is already in operation in a hospital in […]

To access this post, you must purchase The Dark Report.

Medical Robotics Developer Believes It’s Time to Transform Phlebotomy Read More »

Innovations in Lab Testing Arriving at Light Speed

TODAY, IT’S A CHALLENGE TO STAY UP WITH ALL THE NEW THINGS arriving in the lab testing marketplace. Novel assays are launched weekly. That is equally true for next-generation automation and lab analyzers, with vendors regularly announcing something new to their menu of products. The pace of innovation involving information technology is moving even faster.

To access this post, you must purchase The Dark Report.

Innovations in Lab Testing Arriving at Light Speed Read More »

The Dark Report Acquired by LabX Media Group

CEO SUMMARY: One of the clinical laboratory industry’s longest-running sources of business intelligence, market trends, and management developments has a new owner. LabX Media Group completed its purchase of The Dark Intelligence Group, Inc. (TDIG) on Feb. 28, 2025. This transaction paves the way for the retirement of TDIG’s founder and publisher, Robert L. Michel,

To access this post, you must purchase The Dark Report.

The Dark Report Acquired by LabX Media Group Read More »

Quest Acquires ‘Select Assets’ of Fresenius Medical Care

FRESENIUS MEDICAL CARE AND QUEST DIAGNOSTICS AGREED TO A DEAL in which Quest will provide laboratory testing services for the latter’s dialysis clinics in the United States. Separately, Quest Diagnostics will acquire “select assets” of Spectra Laboratories, a wholly owned FMC subsidiary that currently provides those services. FMC is one of the two dominant providers

To access this post, you must purchase The Dark Report.

Quest Acquires ‘Select Assets’ of Fresenius Medical Care Read More »

Medical Robotics Developer Says It’s Time to Transform Phlebotomy

“Our innovation aims to make blood draws fully autonomous, safer, faster, more accurate, less painful, and more accessible.” —Brian Joseph, co-founder, Vitestro CEO SUMMARY: Phlebotomy and collection of veinous blood is one important procedure in clinical laboratory testing that continues to be primarily a manual process. That is about to change. Netherlands-based Vitestro has obtained

To access this post, you must purchase The Dark Report.

Medical Robotics Developer Says It’s Time to Transform Phlebotomy Read More »

Some Health Plans Drop Deductibles as Response to New Consumerism

It may surprise many pathologists and clinical laboratory administrators to learn that one major health insurer’s best-selling plan has only copays and no deductible, no coinsurance, and no cost-shifting! That plan is Surest, a group plan offered by UnitedHealthcare in recent years. Becker’s Payer Issues wrote, “In 2022, the payer introduced Surest, a deductible-free offering

To access this post, you must purchase The Dark Report.

Some Health Plans Drop Deductibles as Response to New Consumerism Read More »

March 10, 2025, Intelligence: Late-Breaking Lab News

Genetic testing is coming to a cruise ship! The New York Post reported that the MV Narrative will be launched this year by Storylines. CruiseCritic describes this vessel as “a residential ship that will create a floating ‘neighborhood’ for a community of up to 1,000 people, including families … With 547 ‘residences,’ owners buy into

To access this post, you must purchase The Dark Report.

March 10, 2025, Intelligence: Late-Breaking Lab News Read More »

Upcoming Executive War College to Cover Important Lab Trends

New developments now changing the landscape in health-care and the clinical laboratory market will be addressed at the upcoming 30th Annual Executive War College on Diagnostic, Clinical Laboratory, and Pathology Management that happens on April 29-30, 2025, in New Orleans. That includes the ongoing uncertainty about the fate of the Food and Drug Administration’s (FDA)

To access this post, you must purchase The Dark Report.

Upcoming Executive War College to Cover Important Lab Trends Read More »

;